Plans and oncologists don't see eye to eye on prior authorization.
作者信息
Reinke Thomas
出版信息
Manag Care. 2011 Sep;20(9):14-6.
PMID:21991856
Abstract
摘要
相似文献
1
Plans and oncologists don't see eye to eye on prior authorization.在事先授权方面，保险公司的计划与肿瘤学家意见不一。
Manag Care. 2011 Sep;20(9):14-6.
2
What do physicians want from health plans?医生对健康保险计划有哪些期望？
Manag Care. 2005 Mar;14(3):14, 16.
3
Balancing the policy with appropriate patient care.使政策与恰当的患者护理相平衡。
Manag Care. 2008 Jul;17(7 Suppl 6):16-9.
4
Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.大陆分水岭？美国和加拿大肿瘤学家对新癌症药物相关成本、成本效益和卫生政策的态度。
J Clin Oncol. 2010 Sep 20;28(27):4149-53. doi: 10.1200/JCO.2010.29.1625. Epub 2010 Aug 9.
5
Managed care restrictions: barriers to product use in cancer care.管理式医疗限制：癌症护理中产品使用的障碍。
Am J Manag Care. 2013 Jan-Feb;19(1 Spec No):SP24-5.
6
CA study finds some challenges in Medicaid may be universal.
Public Sect Contract Rep. 1999 Oct;5(10):158-60.
7
Impact of managed care on physicians' decisions to manipulate reimbursement rules: an explanatory model.管理式医疗对医生操纵报销规则决策的影响：一个解释模型。
J Health Serv Res Policy. 2007 Jul;12(3):147-52. doi: 10.1258/135581907781543102.
8
Value-based reimbursement in oncology.肿瘤学中的基于价值的报销
Am J Manag Care. 2012 May;18(3 Spec No.):SP124-6.
9
StatBite: Survey: Oncologists on Costs and Treatment.
J Natl Cancer Inst. 2009 Nov 4;101(21):1443. doi: 10.1093/jnci/djp388. Epub 2009 Oct 14.
10
2005 TennCare survey validates physician concerns.2005年田纳西医疗补助计划调查证实了医生们的担忧。
Tenn Med. 2005 Nov;98(11):514-5.
引用本文的文献
1
Access to Guideline-Recommended Pharmacogenomic Tests for Cancer Treatments: Experience of Providers and Patients.获得癌症治疗指南推荐的药物基因组学检测：医疗服务提供者和患者的经历。
J Pers Med. 2017 Nov 15;7(4):17. doi: 10.3390/jpm7040017.
Zotero 插件